| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.846 | 0.003 | 0.846 | Cyclooxygenase inhibitor | 0.776 0.003 DBMET00165 0.766 0.003 DBMET00810 0.608 0.004 DBMET00813 | ||
| 0.82 | 0.003 | 0.82 | Cyclooxygenase 2 inhibitor | 0.738 0.003 DBMET00165 0.722 0.003 DBMET00810 0.546 0.004 DBMET00813 | ||
| 0.811 | 0.003 | 0.969 | Non-steroidal antiinflammatory agent | 0.838 0.003 DBMET00165 0.886 0.003 DBMET00810 0.969 0.002 DBMET00813 | DBMET00813 | |
| 0.78 | 0.003 | 0.78 | Cyclooxygenase 1 inhibitor | 0.732 0.004 DBMET00165 0.727 0.004 DBMET00810 0.568 0.004 DBMET00813 | ||
| 0.681 | 0.002 | 0.932 | Carbonic anhydrase XV inhibitor | 0.929 0.001 DBMET00165 0.932 0.001 DBMET00810 0.255 0.012 DBMET00813 | DBMET00810 | |
| 0.593 | 0.003 | 0.758 | Carbonic anhydrase III inhibitor | 0.722 0.002 DBMET00165 0.758 0.002 DBMET00810 0.591 0.003 DBMET00813 | DBMET00810 | |
| 0.537 | 0.003 | 0.811 | Carbonic anhydrase VI inhibitor | 0.811 0.002 DBMET00165 0.807 0.002 DBMET00810 0.453 0.004 DBMET00813 | DBMET00165 | |
| 0.51 | 0.003 | 0.579 | Carbonic anhydrase IX inhibitor | 0.495 0.003 DBMET00165 0.526 0.003 DBMET00810 0.579 0.003 DBMET00813 | DBMET00813 | |
| 0.567 | 0.063 | 0.799 | Antiinflammatory | 0.631 0.045 DBMET00165 0.611 0.05 DBMET00810 0.799 0.015 DBMET00813 | DBMET00813 | |
| 0.464 | 0.003 | 0.537 | Carbonic anhydrase inhibitor | 0.467 0.003 DBMET00165 0.537 0.003 DBMET00810 0.496 0.003 DBMET00813 | DBMET00810 | |
| 0.479 | 0.056 | 0.479 | Analgesic | 0.411 0.08 DBMET00165 0.429 0.073 DBMET00810 0.223 0.211 DBMET00813 | ||
| 0.422 | 0.012 | 0.616 | Diuretic | 0.306 0.021 DBMET00165 0.548 0.005 DBMET00810 0.616 0.004 DBMET00813 | DBMET00813 | |
| 0.414 | 0.004 | 0.626 | Carbonic anhydrase XII inhibitor | 0.397 0.004 DBMET00165 0.479 0.003 DBMET00810 0.626 0.003 DBMET00813 | DBMET00813 | |
| 0.403 | 0.004 | 0.66 | Carbonic anhydrase XIII inhibitor | 0.66 0.003 DBMET00165 0.66 0.003 DBMET00810 0.641 0.003 DBMET00813 | DBMET00810 | |
| 0.401 | 0.004 | 0.401 | Sodium channel (voltage-gated) blocker | 0.37 0.005 DBMET00165 0.288 0.009 DBMET00810 | ||
| 0.399 | 0.005 | 0.488 | Alkaline phosphatase inhibitor | 0.296 0.012 DBMET00165 0.397 0.005 DBMET00810 0.488 0.004 DBMET00813 | DBMET00813 | |
| 0.386 | 0.002 | 0.525 | Carbonic anhydrase VB inhibitor | 0.525 0.002 DBMET00165 0.462 0.002 DBMET00810 0.077 0.024 DBMET00813 | DBMET00165 | |
| 0.377 | 0.005 | 0.377 | Sodium channel blocker | 0.329 0.008 DBMET00165 0.223 0.025 DBMET00810 | ||
| 0.35 | 0.005 | 0.357 | Cyclin-dependent kinase 3 inhibitor | 0.357 0.005 DBMET00165 0.325 0.006 DBMET00810 0.214 0.027 DBMET00813 | DBMET00165 | |
| 0.392 | 0.047 | 0.435 | Caspase 3 stimulant | 0.426 0.037 DBMET00165 0.361 0.056 DBMET00810 0.435 0.034 DBMET00813 | DBMET00813 | |
| 0.337 | 0.004 | 0.413 | Carbonic anhydrase I inhibitor | 0.323 0.004 DBMET00165 0.413 0.003 DBMET00810 0.324 0.004 DBMET00813 | DBMET00810 | |
| 0.373 | 0.044 | 0.421 | Lipoxygenase inhibitor | 0.421 0.032 DBMET00165 0.406 0.036 DBMET00810 | DBMET00165 | |
| 0.333 | 0.004 | 0.378 | Carbonic anhydrase II inhibitor | 0.324 0.004 DBMET00165 0.378 0.003 DBMET00810 0.318 0.004 DBMET00813 | DBMET00810 | |
| 0.329 | 0.004 | 0.329 | Interleukin 2 antagonist | 0.247 0.005 DBMET00165 0.264 0.005 DBMET00810 0.166 0.013 DBMET00813 | ||
| 0.319 | 0.003 | 0.465 | Carbonic anhydrase V inhibitor | 0.465 0.003 DBMET00165 0.394 0.003 DBMET00810 0.095 0.029 DBMET00813 | DBMET00165 | |
| 0.297 | 0.003 | 0.401 | Carbonic anhydrase VA inhibitor | 0.401 0.003 DBMET00165 0.369 0.003 DBMET00810 0.103 0.024 DBMET00813 | DBMET00165 | |
| 0.25 | 0.004 | 0.25 | Nav1.7 sodium channel blocker | 0.219 0.005 DBMET00165 0.132 0.014 DBMET00810 | ||
| 0.298 | 0.055 | 0.326 | Transcription factor STAT3 inhibitor | 0.272 0.068 DBMET00165 0.326 0.042 DBMET00810 | DBMET00810 | |
| 0.277 | 0.044 | 0.277 | EphB2 antagonist | 0.158 0.122 DBMET00165 0.201 0.087 DBMET00810 | ||
| 0.218 | 0.005 | 0.241 | Interleukin 5 antagonist | 0.232 0.005 DBMET00165 0.241 0.005 DBMET00810 0.179 0.007 DBMET00813 | DBMET00810 | |
| 0.277 | 0.069 | 0.289 | Transcription factor STAT inhibitor | 0.23 0.102 DBMET00165 0.289 0.063 DBMET00810 | DBMET00810 | |
| 0.276 | 0.071 | 0.276 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.215 0.091 DBMET00810 | ||
| 0.206 | 0.007 | 0.412 | Electrolyte absorption antagonist | 0.165 0.014 DBMET00165 0.412 0.003 DBMET00810 | DBMET00810 | |
| 0.213 | 0.014 | 0.213 | Ca(v)2.2 blocker | 0.131 0.035 DBMET00165 0.134 0.034 DBMET00810 | ||
| 0.216 | 0.021 | 0.223 | 5-Lipoxygenase inhibitor | 0.223 0.02 DBMET00165 0.22 0.021 DBMET00810 | DBMET00165 | |
| 0.21 | 0.02 | 0.249 | Interleukin 4 antagonist | 0.207 0.02 DBMET00165 0.249 0.013 DBMET00810 0.231 0.016 DBMET00813 | DBMET00810 | |
| 0.233 | 0.047 | 0.233 | Focal adhesion kinase 2 inhibitor | 0.149 0.133 DBMET00165 0.172 0.097 DBMET00810 | ||
| 0.202 | 0.02 | 0.205 | CF transmembrane conductance regulator agonist | 0.205 0.019 DBMET00165 0.149 0.078 DBMET00810 0.167 0.051 DBMET00813 | DBMET00165 | |
| 0.221 | 0.044 | 0.221 | Histone acetyltransferase inhibitor | 0.16 0.125 DBMET00165 0.213 0.051 DBMET00810 | ||
| 0.174 | 0.007 | 0.3 | Factor Xa inhibitor | 0.118 0.011 DBMET00165 0.163 0.008 DBMET00810 0.3 0.004 DBMET00813 | DBMET00813 | |
| 0.166 | 0.006 | 0.166 | Factor X inhibitor | 0.125 0.008 DBMET00165 0.129 0.008 DBMET00810 0.054 0.02 DBMET00813 | ||
| 0.165 | 0.005 | 0.228 | Carbonic anhydrase VII inhibitor | 0.155 0.006 DBMET00165 0.228 0.004 DBMET00810 0.1 0.009 DBMET00813 | DBMET00810 | |
| 0.158 | 0.013 | 0.158 | Nav1.8 sodium channel blocker | 0.142 0.015 DBMET00165 0.155 0.013 DBMET00810 | ||
| 0.144 | 0.005 | 0.144 | Aldosterone antagonist | 0.06 0.02 DBMET00165 0.097 0.008 DBMET00810 | ||
| 0.163 | 0.025 | 0.187 | Heat shock protein 70 antagonist | 0.158 0.03 DBMET00165 0.187 0.009 DBMET00810 0.185 0.01 DBMET00813 | DBMET00810 | |
| 0.144 | 0.013 | 0.17 | Prostaglandin-E synthase inhibitor | 0.134 0.015 DBMET00165 0.17 0.009 DBMET00810 | DBMET00810 | |
| 0.16 | 0.038 | 0.16 | Pregnane X receptor agonist | 0.132 0.094 DBMET00165 | ||
| 0.129 | 0.01 | 0.129 | Cannabinoid CB1 receptor antagonist | 0.08 0.027 DBMET00165 | ||
| 0.124 | 0.005 | 0.148 | Carbonic anhydrase IV inhibitor | 0.128 0.004 DBMET00165 0.148 0.004 DBMET00810 0.05 0.025 DBMET00813 | DBMET00810 | |
| 0.123 | 0.007 | 0.421 | Carbonic anhydrase XIV inhibitor | 0.249 0.004 DBMET00165 0.323 0.003 DBMET00810 0.421 0.003 DBMET00813 | DBMET00813 | |
| 0.134 | 0.019 | 0.159 | Phosphodiesterase 3A inhibitor | 0.159 0.014 DBMET00165 0.092 0.04 DBMET00810 | DBMET00165 | |
| 0.168 | 0.054 | 0.168 | Activin receptor-like kinase 2 inhibitor | 0.148 0.068 DBMET00165 | ||
| 0.132 | 0.021 | 0.152 | I kappa B kinase inhibitor | 0.152 0.016 DBMET00165 0.126 0.024 DBMET00810 | DBMET00165 | |
| 0.148 | 0.039 | 0.148 | Calcium channel N-type blocker | 0.103 0.089 DBMET00165 0.113 0.073 DBMET00810 | ||
| 0.272 | 0.164 | 0.272 | MAP kinase kinase 6 inhibitor | 0.234 0.213 DBMET00810 | ||
| 0.145 | 0.043 | 0.145 | Cyclin-dependent kinase 1 inhibitor | 0.129 0.05 DBMET00165 0.088 0.075 DBMET00810 | ||
| 0.104 | 0.005 | 0.104 | Purinergic P2X4 antagonist | 0.094 0.005 DBMET00165 0.091 0.005 DBMET00810 | ||
| 0.133 | 0.034 | 0.133 | CDK2/cyclin A inhibitor | 0.113 0.048 DBMET00165 0.096 0.061 DBMET00810 | ||
| 0.114 | 0.014 | 0.114 | Potassium channel Kv1.5 blocker | 0.068 0.03 DBMET00165 0.05 0.048 DBMET00810 | ||
| 0.12 | 0.022 | 0.12 | Cannabinoid receptor antagonist | |||
| 0.104 | 0.011 | 0.12 | I kappa B kinase 2 inhibitor | 0.12 0.008 DBMET00165 0.092 0.016 DBMET00810 | DBMET00165 | |
| 0.136 | 0.044 | 0.136 | Cyclin-dependent kinase 2 inhibitor | 0.107 0.063 DBMET00165 0.093 0.078 DBMET00810 | ||
| 0.147 | 0.058 | 0.147 | Nav1.6 sodium channel blocker | 0.117 0.101 DBMET00165 | ||
| 0.13 | 0.041 | 0.13 | Sphingosine 1-phosphate receptor 2 agonist | 0.114 0.066 DBMET00165 0.108 0.079 DBMET00810 | ||
| 0.103 | 0.02 | 0.103 | Ca(v)3.1 blocker | 0.079 0.064 DBMET00165 0.08 0.059 DBMET00810 | ||
| 0.147 | 0.067 | 0.163 | MAP kinase kinase 4 inhibitor | 0.146 0.07 DBMET00165 0.163 0.04 DBMET00810 | DBMET00810 | |
| 0.098 | 0.024 | 0.098 | CC chemokine 5 receptor agonist | |||
| 0.152 | 0.078 | 0.291 | Anticoagulant | 0.163 0.07 DBMET00165 0.194 0.055 DBMET00810 0.291 0.03 DBMET00813 | DBMET00813 | |
| 0.124 | 0.05 | 0.124 | CDK3/cyclin E inhibitor | 0.123 0.052 DBMET00165 0.123 0.051 DBMET00810 | ||
| 0.243 | 0.17 | 0.243 | 15-Lipoxygenase inhibitor | 0.226 0.186 DBMET00810 | ||
| 0.109 | 0.038 | 0.169 | Phosphodiesterase 6D inhibitor | 0.1 0.051 DBMET00165 0.1 0.051 DBMET00810 0.169 0.006 DBMET00813 | DBMET00813 | |
| 0.113 | 0.046 | 0.179 | Creatine kinase inhibitor | 0.091 0.07 DBMET00165 0.179 0.014 DBMET00810 | DBMET00810 | |
| 0.078 | 0.012 | 0.078 | Mineralocorticoid receptor antagonist | 0.06 0.02 DBMET00165 0.07 0.014 DBMET00810 | ||
| 0.082 | 0.017 | 0.082 | Cyclin H inhibitor | 0.069 0.03 DBMET00165 0.065 0.034 DBMET00810 | ||
| 0.11 | 0.045 | 0.113 | Phosphodiesterase 7B inhibitor | 0.089 0.071 DBMET00165 0.113 0.043 DBMET00810 | DBMET00810 | |
| 0.064 | 0.005 | 0.064 | AMPA receptor agonist | 0.064 0.005 DBMET00165 0.063 0.005 DBMET00810 0.036 0.023 DBMET00813 | ||
| 0.081 | 0.022 | 0.092 | Nitric oxide donor | 0.081 0.021 DBMET00165 0.085 0.018 DBMET00810 0.092 0.013 DBMET00813 | DBMET00813 | |
| 0.227 | 0.17 | 0.307 | Toll-Like receptor 7 agonist | 0.307 0.106 DBMET00165 0.306 0.106 DBMET00810 0.235 0.162 DBMET00813 | DBMET00165 | |
| 0.098 | 0.043 | 0.098 | Bromodomain-containing protein 2 inhibitor | |||
| 0.149 | 0.095 | 0.159 | Antipruritic | 0.159 0.084 DBMET00810 | DBMET00810 | |
| 0.203 | 0.151 | 0.203 | Thyroid hormone beta antagonist | |||
| 0.058 | 0.006 | 0.125 | Liver X receptor beta antagonist | 0.125 0.003 DBMET00165 0.079 0.004 DBMET00810 | DBMET00165 | |
| 0.123 | 0.072 | 0.123 | Cathepsin H inhibitor | 0.121 0.074 DBMET00810 | ||
| 0.132 | 0.083 | 0.14 | Mannose-6-phosphate isomerase inhibitor | 0.12 0.1 DBMET00165 0.14 0.074 DBMET00810 0.13 0.086 DBMET00813 | DBMET00810 | |
| 0.085 | 0.037 | 0.092 | Epoxide hydrolase inhibitor | 0.064 0.062 DBMET00165 0.092 0.03 DBMET00810 | DBMET00810 | |
| 0.072 | 0.027 | 0.072 | Transcription factor RelA inhibitor | |||
| 0.055 | 0.009 | 0.122 | Liver X receptor beta agonist | 0.122 0.004 DBMET00165 0.063 0.008 DBMET00810 | DBMET00165 | |
| 0.081 | 0.036 | 0.094 | Phosphodiesterase 4B inhibitor | 0.094 0.028 DBMET00165 0.091 0.029 DBMET00810 | DBMET00165 | |
| 0.134 | 0.092 | 0.164 | Sphingosine 1-phosphate receptor 5 antagonist | 0.164 0.041 DBMET00810 | DBMET00810 | |
| 0.062 | 0.02 | 0.062 | Carbonic anhydrase II stimulant | 0.053 0.033 DBMET00165 0.055 0.03 DBMET00810 | ||
| 0.067 | 0.027 | 0.067 | Ca(v)3.2 blocker | |||
| 0.052 | 0.014 | 0.052 | Glucocorticoid antagonist | 0.032 0.023 DBMET00165 0.029 0.024 DBMET00810 | ||
| 0.279 | 0.243 | 0.279 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.046 | 0.011 | 0.073 | Liver X receptor antagonist | 0.073 0.006 DBMET00165 0.049 0.01 DBMET00810 | DBMET00165 | |
| 0.151 | 0.117 | 0.17 | Interleukin antagonist | 0.155 0.114 DBMET00165 0.17 0.104 DBMET00810 | DBMET00810 | |
| 0.08 | 0.046 | 0.088 | Sphingosine 1-phosphate receptor antagonist | 0.085 0.037 DBMET00165 0.088 0.033 DBMET00810 | DBMET00810 | |
| 0.075 | 0.042 | 0.075 | ZAP-70 protein tyrosine kinase inhibitor | 0.065 0.054 DBMET00165 | ||
| 0.093 | 0.062 | 0.201 | Potassium channel (Ca-activated) activator | 0.201 0.014 DBMET00810 | DBMET00810 | |
| 0.052 | 0.021 | 0.07 | Liver X receptor agonist | 0.07 0.013 DBMET00165 0.051 0.022 DBMET00810 | DBMET00165 | |
| 0.137 | 0.108 | 0.212 | Dual specificity phosphatase 3 inhibitor | 0.155 0.092 DBMET00165 0.212 0.055 DBMET00810 | DBMET00810 | |
| 0.069 | 0.04 | 0.069 | Aryl hydrocarbon receptor antagonist | |||
| 0.214 | 0.185 | 0.303 | Toll-Like receptor agonist | 0.303 0.109 DBMET00165 0.292 0.116 DBMET00810 0.242 0.156 DBMET00813 | DBMET00165 | |
| 0.064 | 0.036 | 0.064 | Carbonic anhydrase stimulant | |||
| 0.059 | 0.032 | 0.07 | Sphingosine 1-phosphate receptor 1 antagonist | 0.07 0.018 DBMET00165 0.065 0.022 DBMET00810 | DBMET00165 | |
| 0.176 | 0.15 | 0.176 | Streptokinase A inhibitor | |||
| 0.121 | 0.095 | 0.126 | Sphingosine 1-phosphate receptor 2 antagonist | 0.126 0.083 DBMET00810 | DBMET00810 | |
| 0.227 | 0.203 | 0.227 | Transcription factor inhibitor | |||
| 0.063 | 0.042 | 0.063 | Cyclin A inhibitor | |||
| 0.096 | 0.078 | 0.114 | Factor V inhibitor | 0.096 0.078 DBMET00165 0.114 0.045 DBMET00810 | DBMET00810 | |
| 0.093 | 0.075 | 0.093 | Urease inhibitor | 0.088 0.08 DBMET00810 | ||
| 0.032 | 0.016 | 0.048 | Liver X receptor alpha antagonist | 0.048 0.006 DBMET00165 0.035 0.012 DBMET00810 | DBMET00165 | |
| 0.061 | 0.046 | 0.061 | Cyclin A2 inhibitor | |||
| 0.1 | 0.085 | 0.1 | Nav1.5 sodium channel blocker | |||
| 0.04 | 0.025 | 0.055 | Glutamate (mGluR group II) antagonist | 0.052 0.015 DBMET00165 0.055 0.013 DBMET00810 | DBMET00810 | |
| 0.122 | 0.107 | 0.147 | CC chemokine 6 receptor antagonist | 0.132 0.064 DBMET00810 0.147 0.027 DBMET00813 | DBMET00813 | |
| 0.187 | 0.173 | 0.187 | Thyroid hormone antagonist | |||
| 0.22 | 0.21 | 0.22 | DNA polymerase beta inhibitor | |||
| 0.03 | 0.02 | 0.037 | Glutamate (mGluR2) antagonist | 0.037 0.013 DBMET00165 0.035 0.015 DBMET00810 | DBMET00165 | |
| 0.021 | 0.011 | 0.021 | Factor IX inhibitor | 0.017 0.015 DBMET00165 0.018 0.013 DBMET00810 | ||
| 0.071 | 0.062 | 0.071 | CC chemokine receptor antagonist | |||
| 0.014 | 0.007 | 0.02 | Carbonic anhydrase XI inhibitor | 0.02 0.004 DBMET00810 | DBMET00810 | |
| 0.032 | 0.025 | 0.032 | Calcium release-activated channel blocker | |||
| 0.038 | 0.032 | 0.039 | Phenylethanolamine N methyltransferase inhibitor | 0.039 0.031 DBMET00165 | DBMET00165 | |
| 0.113 | 0.107 | 0.113 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.062 | 0.057 | 0.065 | CDK1/cyclin B1 inhibitor | 0.065 0.054 DBMET00165 | DBMET00165 | |
| 0.034 | 0.03 | 0.084 | Glutamate (mGluR3) antagonist | 0.048 0.014 DBMET00165 0.084 0.005 DBMET00810 | DBMET00810 | |
| 0.068 | 0.064 | 0.068 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.057 | 0.054 | 0.058 | Heme oxygenase stimulant | 0.058 0.053 DBMET00810 | DBMET00810 | |
| 0.107 | 0.105 | 0.107 | Calcium channel blocker | |||
| 0.014 | 0.017 | 0.03 | Carbonic anhydrase X inhibitor | 0.03 0.004 DBMET00810 | DBMET00810 | |
| 0.014 | 0.017 | 0.03 | Carbonic anhydrase VIII inhibitor | 0.03 0.004 DBMET00810 | DBMET00810 | |
| 0.06 | 0.063 | 0.062 | MAP kinase kinase 8 inhibitor | 0.062 0.059 DBMET00165 | DBMET00165 | |
| 0.033 | 0.036 | 0.07 | Urate transporter 1 inhibitor | 0.07 0.01 DBMET00810 | DBMET00810 | |
| 0.192 | 0.199 | 0.301 | Sodium/bile acid cotransporter inhibitor | 0.215 0.168 DBMET00165 0.301 0.078 DBMET00810 0.241 0.138 DBMET00813 | DBMET00810 | |
| 0.135 | 0.144 | 0.14 | Neurotensin receptor agonist | 0.14 0.13 DBMET00810 | DBMET00810 | |
| 0.011 | 0.02 | 0.015 | G-protein-coupled receptor 120 agonist | 0.015 0.014 DBMET00165 | DBMET00165 | |
| 0.13 | 0.141 | 0.237 | ATPase inhibitor | 0.237 0.017 DBMET00813 | DBMET00813 | |
| 0.031 | 0.048 | 0.053 | Liver X receptor alpha agonist | 0.053 0.017 DBMET00165 | DBMET00165 | |
| 0.122 | 0.139 | 0.173 | Amyloid beta precursor protein antagonist | 0.173 0.079 DBMET00810 | DBMET00810 | |
| 0.05 | 0.068 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.053 DBMET00813 | DBMET00813 | |
| 0.053 | 0.073 | 0.059 | Trypsin inhibitor | 0.059 0.052 DBMET00810 | DBMET00810 | |
| 0.01 | 0.03 | 0.04 | Prostaglandin EP1 antagonist | 0.018 0.015 DBMET00165 0.04 0.008 DBMET00810 | DBMET00810 | |
| 0.018 | 0.046 | 0.023 | Glutamate (mGluR1) agonist | 0.023 0.022 DBMET00810 | DBMET00810 | |
| 0.068 | 0.104 | 0.093 | Aminoacyl-tRNA synthetase inhibitor | 0.093 0.054 DBMET00165 0.086 0.066 DBMET00810 0.08 0.078 DBMET00813 | DBMET00165 | |
| 0.023 | 0.066 | 0.042 | Dihydropteroate synthase inhibitor | 0.042 0.024 DBMET00810 | DBMET00810 | |
| 0.019 | 0.068 | 0.037 | TRPM8 blocker | 0.037 0.028 DBMET00810 | DBMET00810 | |
| 0.103 | 0.159 | 0.387 | Hemostatic | 0.13 0.095 DBMET00165 0.136 0.086 DBMET00810 0.387 0.009 DBMET00813 | DBMET00813 | |
| 0.049 | 0.106 | 0.073 | Phosphodiesterase IV inhibitor | 0.073 0.07 DBMET00165 | DBMET00165 | |
| 0.119 | 0.176 | 0.285 | Aldehyde oxidase inhibitor | 0.285 0.071 DBMET00810 | DBMET00810 | |
| 0.106 | 0.168 | 0.168 | Dual specificity phosphatase inhibitor | 0.168 0.076 DBMET00810 | DBMET00810 | |
| 0.033 | 0.096 | 0.088 | Factor IXa inhibitor | 0.088 0.013 DBMET00813 | DBMET00813 | |
| 0.027 | 0.091 | 0.042 | AICAR transformylase inhibitor | 0.042 0.034 DBMET00810 | DBMET00810 | |
| 0.028 | 0.098 | 0.042 | Guanylate cyclase stimulant | 0.042 0.034 DBMET00810 | DBMET00810 | |
| 0.042 | 0.135 | 0.075 | Potassium channel large-conductance Ca-activated activator | 0.075 0.039 DBMET00810 | DBMET00810 | |
| 0.088 | 0.187 | 0.232 | Hexokinase inhibitor | 0.164 0.064 DBMET00810 0.232 0.021 DBMET00813 | DBMET00813 | |
| 0.019 | 0.134 | 0.073 | Prostaglandin E2 antagonist | 0.073 0.022 DBMET00810 | DBMET00810 | |
| 0.056 | 0.173 | 0.106 | Thioredoxin inhibitor | 0.106 0.042 DBMET00813 | DBMET00813 | |
| 0.014 | 0.138 | 0.042 | AMPA receptor antagonist | 0.042 0.041 DBMET00810 | DBMET00810 | |
| 0.01 | 0.137 | 0.048 | Sodium/glucose cotransporter inhibitor | 0.048 0.005 DBMET00813 | DBMET00813 | |
| 0.055 | 0.193 | 0.087 | ABCA1 expression enhancer | 0.087 0.07 DBMET00810 | DBMET00810 | |
| 0.144 | 0.284 | 0.253 | Antiobesity | 0.253 0.154 DBMET00813 | DBMET00813 | |
| 0.127 | 0.273 | 0.358 | Peptidyltransferase inhibitor | 0.165 0.157 DBMET00810 0.358 0.011 DBMET00813 | DBMET00813 | |
| 0.046 | 0.192 | 0.127 | Uric acid excretion stimulant | 0.127 0.034 DBMET00810 0.113 0.042 DBMET00813 | DBMET00810 | |
| 0.052 | 0.207 | 0.286 | Amylase inhibitor | 0.286 0.02 DBMET00813 | DBMET00813 | |
| 0.063 | 0.231 | 0.14 | Mcl-1 antagonist | 0.14 0.1 DBMET00810 | DBMET00810 | |
| 0.035 | 0.204 | 0.1 | Protein kinase (CK2) alpha inhibitor | 0.1 0.077 DBMET00810 | DBMET00810 | |
| 0.043 | 0.22 | 0.093 | Ferrochelatase inhibitor | 0.093 0.079 DBMET00810 | DBMET00810 | |
| 0.122 | 0.299 | 0.393 | Alpha-glucosidase inhibitor | 0.393 0.118 DBMET00813 | DBMET00813 | |
| 0.099 | 0.307 | 0.48 | Transcription factor NF kappa B inhibitor | 0.48 0.047 DBMET00813 | DBMET00813 | |
| 0.009 | 0.24 | 0.028 | Purinergic P2Y14 antagonist | 0.028 0.024 DBMET00810 | DBMET00810 | |
| 0.067 | 0.336 | 0.337 | Tumour necrosis factor alpha release inhibitor | 0.337 0.041 DBMET00813 | DBMET00813 | |
| 0.032 | 0.322 | 0.18 | AMP-activated protein kinase stimulant | 0.18 0.015 DBMET00813 | DBMET00813 | |
| 0.072 | 0.392 | 0.155 | Lipocortins synthesis antagonist | 0.155 0.098 DBMET00810 | DBMET00810 | |
| 0.051 | 0.372 | 0.32 | Platelet adhesion inhibitor | 0.32 0.028 DBMET00813 | DBMET00813 | |
| 0.027 | 0.388 | 0.11 | Beta glucuronidase inhibitor | 0.11 0.057 DBMET00813 | DBMET00813 | |
| 0.103 | 0.464 | 0.459 | Apoptosis agonist | 0.459 0.088 DBMET00813 | DBMET00813 | |
| 0.078 | 0.443 | 0.349 | Immunomodulator | 0.349 0.06 DBMET00813 | DBMET00813 | |
| 0.064 | 0.438 | 0.198 | Angiogenesis inhibitor | 0.198 0.172 DBMET00813 | DBMET00813 | |
| 0.055 | 0.432 | 0.127 | Interferon gamma antagonist | 0.127 0.117 DBMET00813 | DBMET00813 | |
| 0.05 | 0.448 | 0.129 | DNA repair enzyme inhibitor | 0.129 0.056 DBMET00813 | DBMET00813 | |
| 0.053 | 0.452 | 0.133 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.133 0.109 DBMET00810 | DBMET00810 | |
| 0.048 | 0.461 | 0.193 | NOS3 expression enhancer | 0.193 0.044 DBMET00813 | DBMET00813 | |
| 0.068 | 0.487 | 0.202 | Histamine release inhibitor | 0.202 0.2 DBMET00813 | DBMET00813 | |
| 0.058 | 0.48 | 0.461 | Antithrombotic | 0.461 0.035 DBMET00813 | DBMET00813 | |
| 0.029 | 0.497 | 0.218 | Platelet antagonist | 0.218 0.089 DBMET00813 | DBMET00813 | |
| 0.026 | 0.519 | 0.405 | Free radical scavenger | 0.405 0.028 DBMET00813 | DBMET00813 | |
| 0.024 | 0.538 | 0.149 | Cell wall synthesis inhibitor | 0.149 0.067 DBMET00813 | DBMET00813 | |
| 0.046 | 0.568 | 0.532 | Antibacterial | 0.532 0.032 DBMET00813 | DBMET00813 | |
| 0.007 | 0.532 | 0.038 | Retinoic acid alpha receptor agonist | 0.038 0.03 DBMET00810 | DBMET00810 | |
| 0.063 | 0.594 | 0.335 | Apoptosis antagonist | 0.335 0.063 DBMET00813 | DBMET00813 | |
| 0.025 | 0.558 | 0.138 | Toll-Like receptor 4 antagonist | 0.138 0.029 DBMET00813 | DBMET00813 | |
| 0.026 | 0.575 | 0.165 | Insulin secretagoues | 0.165 0.06 DBMET00813 | DBMET00813 | |
| 0.011 | 0.58 | 0.052 | Heparanase inhibitor | 0.052 0.041 DBMET00813 | DBMET00813 | |
| 0.024 | 0.739 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.046 DBMET00813 | DBMET00813 | |
| 0.007 | 0.742 | 0.071 | Protein 50S ribosomal subunit inhibitor | 0.071 0.024 DBMET00813 | DBMET00813 | |
| 0.009 | 0.761 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.026 DBMET00813 | DBMET00813 | |
| 0.008 | 0.762 | 0.163 | Immunostimulant | 0.163 0.144 DBMET00813 | DBMET00813 | |
| 0.02 | 0.795 | 0.447 | Hypoglycemic | 0.447 0.021 DBMET00813 | DBMET00813 | |
| 0.019 | 0.796 | 0.596 | Cyclophilin D inhibitor | 0.596 0.028 DBMET00813 | DBMET00813 | |
| 0.015 | 0.826 | 0.32 | Immunosuppressant | 0.32 0.103 DBMET00813 | DBMET00813 | |
| 0.007 | 0.844 | 0.186 | Thrombolytic | 0.186 0.059 DBMET00813 | DBMET00813 | |
| 0.005 | 0.844 | 0.377 | Antioxidant | 0.377 0.039 DBMET00813 | DBMET00813 | |
| 0.006 | 0.876 | 0.103 | Cell adhesion inhibitor | 0.103 0.084 DBMET00813 | DBMET00813 | |
| 0.039 | 0.909 | 0.319 | Interleukin 2 agonist | 0.319 0.061 DBMET00813 | DBMET00813 | |
| 0.003 | 0.883 | 0.261 | Selectin antagonist | 0.261 0.008 DBMET00813 | DBMET00813 | |
| 0.002 | 0.942 | 0.023 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 DBMET00813 | DBMET00813 | |
| 0.011 | 0.952 | 0.277 | Hepatoprotectant | 0.277 0.036 DBMET00813 | DBMET00813 | |
| 0.004 | 0.952 | 0.209 | Nitric oxide antagonist | 0.209 0.064 DBMET00813 | DBMET00813 | |
| 0.003 | 0.979 | 0.055 | Antibiotic Aminoglycoside-like | 0.055 0.011 DBMET00813 | DBMET00813 | |
| 0.004 | 0.991 | 0.416 | Angiogenesis stimulant | 0.416 0.019 DBMET00813 | DBMET00813 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |